Relationship of cerebral blood flow and metabolism to neurological symptoms.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001345:Autoradiography; D001783:Blood Flow Velocity; D001784:Blood Gas Analysis; D001921:Brain / Q000378:metabolism*; D002245:Carbon Dioxide / Q000378:metabolism; D002533:Cerebral Angiography; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D004569:Electroencephalography; D004827:Epilepsy / Q000503:physiopathology; D004837:Epinephrine / Q000494:pharmacology; D005112:Extracorporeal Circulation; D005334:Fever; D006801:Humans; D006859:Hydrogen; D006863:Hydrogen-Ion Concentration; D006973:Hypertension / Q000503:physiopathology; D006985:Hyperventilation; D007035:Hypothermia; D002546:Ischemic Attack, Transient / Q000503:physiopathology; D009609:Nitrous Oxide; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption; D010992:Plethysmography, Impedance; D012039:Regional Blood Flow; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D002245:Carbon Dioxide; D006859:Hydrogen; D009609:Nitrous Oxide; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine